Literature DB >> 10509605

Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study.

C D Sjöström1, L Lissner, H Wedel, L Sjöström.   

Abstract

OBJECTIVE: To examine the effect of a large, long standing and intentional weight reduction on the incidence of diabetes, hypertension and lipid disturbances in severely obese individuals as compared to weight-stable obese controls. RESEARCH METHODS AND PROCEDURES: The ongoing prospective SOS (Swedish Obese Subjects) intervention consists of a surgically treated group and a matched control group obtaining conventional obesity treatment. This report is based on 845 surgically treated patients and 845 controls (BMI 41.0+/-4.6 kg/m2 (mean+/-standard deviation [S])) followed for 2 years.
RESULTS: Surgically treated patients lost 28+/-15 kg and controls 0.5+/-8.9 kg (p<0.0001). Two-year incidence of hypertension, diabetes, hyperinsulinemia, and lipid disturbances was compared in the two treatment groups. Adjusted odds ratios (95% CI) for the surgically treated group versus controls were 0.38 (0.22, 0.65) for hypertension, 0.02 (0.00, 0.16) for diabetes, 0.10 (0.03, 0.28) for hyperinsulinemia, 0. 10 (0.04, 0.25) for hypertriglyceridemia, 0.28 (0.16, 0.49) for low HDL-cholesterol and 1.24 (0.84, 1.8) for hypercholesterolemia. Compared to controls, the 2-year recovery rates from hypertension, diabetes, hypo-HDL, and hypertriglyceridemia were significantly higher in the surgically treated group. DISCUSSION: Intentional weight loss in the obese causes a marked reduction in the 2-year incidence of hypertension, diabetes and some lipid disturbances. The results suggest that severe obesity can and should be treated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10509605     DOI: 10.1002/j.1550-8528.1999.tb00436.x

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  122 in total

1.  Predictors of Remission of T2DM and Metabolic Effects after Laparoscopic Roux-en-y Gastric Bypass in Obese Indian Diabetics-a 5-Year Study.

Authors:  Aparna Govil Bhasker; Carlyne Remedios; Payal Batra; Amit Sood; Shehla Shaikh; Muffazal Lakdawala
Journal:  Obes Surg       Date:  2015-07       Impact factor: 4.129

2.  First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis.

Authors:  N Basso; D Capoccia; M Rizzello; F Abbatini; P Mariani; C Maglio; F Coccia; G Borgonuovo; M L De Luca; R Asprino; G Alessandri; G Casella; F Leonetti
Journal:  Surg Endosc       Date:  2011-06-03       Impact factor: 4.584

3.  Effect of Roux-en-Y gastric bypass vs sleeve gastrectomy on glucose and gut hormones: a prospective randomised trial.

Authors:  José Manuel Ramón; Silvia Salvans; Xenia Crous; Sonia Puig; Albert Goday; David Benaiges; Lourdes Trillo; Manuel Pera; Luis Grande
Journal:  J Gastrointest Surg       Date:  2012-03-09       Impact factor: 3.452

Review 4.  The major diabetes prevention trials.

Authors:  Jaakko Tuomilehto; Jaana Lindström
Journal:  Curr Diab Rep       Date:  2003-04       Impact factor: 4.810

Review 5.  acp Best Practice No 168. The investigation and management of obesity.

Authors:  M Labib
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

6.  Diabetes and obesity: medical diseases, surgical cure?

Authors:  Vanita R Aroda; Michelle K Savu; Robert R Henry
Journal:  Curr Diab Rep       Date:  2004-10       Impact factor: 4.810

7.  Citation Analysis in Bariatric Surgery.

Authors:  Ali Aminian; Stacy A Brethauer; Philip R Schauer
Journal:  Obes Surg       Date:  2015-12       Impact factor: 4.129

8.  An Update on Bariatric Surgery.

Authors:  Michael Laffin; Shahzeer Karmali
Journal:  Curr Obes Rep       Date:  2014-09

Review 9.  Obesity and sedentary lifestyle: modifiable risk factors for prevention of type 2 diabetes.

Authors:  E J Mayer-Davis; T Costacou
Journal:  Curr Diab Rep       Date:  2001-10       Impact factor: 4.810

10.  Diet, Weight Loss, and Cardiovascular Disease Prevention.

Authors:  George A. Bray; Donna H. Ryan; David W. Harsha
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.